RPG Life Sciences (NSE:RPGLIFE, BOM:532983) reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.
Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.
Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.
Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.